Verv Technologies has completed the alpha prototype of its proprietary blood-testing device, putting the company a step closer to getting regulatory approval.
The Sudbury company is the inventor of the Vi Home Health Monitor, a medical technology device designed to be used at home to test for a variety of health markers.
By applying a drop of blood, a user will be able to test for things like vitamin D, glucose, and cholesterol. Test results are available in 15 minutes and can be delivered via the user’s smartphone.
"With this alpha prototype, we are just steps away from having the Vi Home Health Monitor completed and commercially ready,” Jeff Sutton, Verv’s founder and president, said in an Oct. 29 news release.
“Verv’s Vi monitor will bring comprehensive biomarker analysis into the home. Our test cartridge will have the capacity to include up to 12 assays on one cartridge, allowing for a variety of testing options without the user needing to leave home. It’s the future of bloodwork in health care.”
SEE: Sudbury med-tech startup bringing blood tests to your home
SEE: Sudbury-devised consumer blood test kit makes its market debut in 2023
The prototype includes the Vi analyzer, Vi test cartridges, and a mobile app for users wanting results posted directly to their smartphone or other device.
Verv said that completing an alpha prototype is required to receive regulatory approval for medical devices.
The company said it has additional test assays in development including lipid panels, glucose, liver, kidney panels, and will continue to expand to hormones and vitamin panels to meet the growing demand for in-home testing.
Its target market is health-conscious consumers who want to take preventive measures in maintaining their health.
